Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Just found this. Whisper numbers.

"3rd Quarter September 2015
Consensus: ($0.13)
Revenue: $35.50 Mil”

This would be a .17 cent improvement from last quarter if it comes in like this. -.04 to +.13 a share.

Expected Earnings release 11/5

What might give added pop to this quarter is, we will have broken into the black for the quarter. The big question on all stocks is can you bring profit to the bottom line.
There are a ton of stocks selling much higher than MNTA that have big negative earnings. I know the potential. Yes, sometimes. My wise broker says it doesn’t mean anything if a company can’t bring a profit to the bottom line. 10 Mass Biotech stocks collapsed in the last two months.
We are ahead of them on just starting to reach our potential and will have profit to the bottom line. Plus we have more shares outstanding now which impacts the earnings per share.

Oct/1 added Glatopa first line.

http://www.myriversidehealth.com/Portals/0/Files/Upcoming%20Formulary%20Changes%20Provider%20Notification%2010-1-2015.pdf

Added 9/1

http://www.aetnabetterhealth.com/ny/assets/pdf/members/formulary-updates/NY%20Duals-2015%20Formulary%20Updates%20Sept2015.pdf

Check out Stiff Person Syndrome (SPS), Never new that disease existed. A very interesting disease that makes one afraid of noise as well as making them stiff. I relate to loud noises making me jump in my old age.

It might be one of many perfect uses for our HSIVIg, once approved, and at a much lower price I would suspect.


Boing X 2